WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+11.55%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$8.41B
AUM Growth
+$1.34B
(+19%)
Cap. Flow
+$970M
Cap. Flow
% of AUM
11.53%
Top 10 Holdings %
Top 10 Hldgs %
15.67%
Holding
835
New
215
Increased
181
Reduced
162
Closed
219
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$126M |
| 2 |
Cencora
COR
|
$118M |
| 3 |
HES
Hess
HES
|
$114M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$112M |
| 5 |
Microsoft
MSFT
|
$110M |
Top Sells
| 1 |
Keysight
KEYS
|
$109M |
| 2 |
Baxter International
BAX
|
$108M |
| 3 |
Analog Devices
ADI
|
$105M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$76.6M |
| 5 |
Booking.com
BKNG
|
$58.2M |
Sector Composition
| 1 | Healthcare | 37.65% |
| 2 | Technology | 28.08% |
| 3 | Industrials | 9.46% |
| 4 | Energy | 7.76% |
| 5 | Consumer Discretionary | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CORS
276
DELISTED
Corsair Partnering Corporation
CORS
| $5.44M | 0.06% |
525,001
| – | – |
|
277
Olema Pharmaceuticals
OLMA
$570M
| $5.31M | 0.06% |
+588,052
| New | +$5.31M |
|
278
Larimar Therapeutics
LRMR
$337M
| $5.26M | 0.06% |
1,681,913
| – | – |
|
279
NVIDIA
NVDA
$4.07T
| $5.21M | 0.06% |
123,120
-329,590
| -73% | -$13.9M |
|
280
Krystal Biotech
KRYS
$4.35B
| $5.19M | 0.06% |
+44,223
| New | +$5.19M |
|
281
BlackRock Municipal Income Trust
BFK
$430M
| $5.15M | 0.06% |
518,150
-213,008
| -29% | -$2.12M |
|
282
PROS Holdings
PRO
$746M
| $5.14M | 0.06% |
166,892
+5,985
| +4% | +$184K |
|
283
Evolent Health
EVH
$1.11B
| $5.11M | 0.06% |
+168,500
| New | +$5.11M |
|
284
Amdocs
DOX
$9.46B
| $5.08M | 0.06% |
51,422
-16,709
| -25% | -$1.65M |
|
285
Interpublic Group of Companies
IPG
$9.94B
| $5.04M | 0.06% |
130,676
-578,979
| -82% | -$22.3M |
|
286
Arcus Biosciences
RCUS
$1.3B
| $5.04M | 0.06% |
+248,000
| New | +$5.04M |
|
287
BridgeBio Pharma
BBIO
$10.2B
| $4.99M | 0.06% |
290,000
-23,195
| -7% | -$399K |
|
288
Teladoc Health
TDOC
$1.38B
| $4.97M | 0.06% |
+196,235
| New | +$4.97M |
|
|
FORG
289
DELISTED
ForgeRock, Inc.
FORG
| $4.95M | 0.06% |
241,204
-163,128
| -40% | -$3.35M |
|
290
Exelixis
EXEL
$10.2B
| $4.95M | 0.06% |
+259,000
| New | +$4.95M |
|
291
BioNTech
BNTX
$27B
| $4.94M | 0.06% |
+45,800
| New | +$4.94M |
|
292
Ventyx Biosciences
VTYX
$180M
| $4.92M | 0.06% |
150,000
+23,286
| +18% | +$764K |
|
|
FDEU
293
DELISTED
First Trust Dynamic Europe Equity Income Fund
FDEU
| $4.91M | 0.06% |
374,816
| – | – |
|
|
EOCW
294
DELISTED
Elliott Opportunity II Corp.
EOCW
| $4.91M | 0.06% |
474,000
| – | – |
|
295
Pool Corp
POOL
$12.4B
| $4.86M | 0.06% |
12,963
-75,236
| -85% | -$28.2M |
|
296
Aurinia Pharmaceuticals
AUPH
$1.63B
| $4.84M | 0.06% |
500,000
-453,462
| -48% | -$4.39M |
|
297
Acadia Healthcare
ACHC
$2.19B
| $4.77M | 0.06% |
59,896
-4,340
| -7% | -$346K |
|
|
SUM
298
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $4.72M | 0.06% |
+124,668
| New | +$4.72M |
|
299
Pliant Therapeutics
PLRX
$114M
| $4.67M | 0.06% |
+257,498
| New | +$4.67M |
|
300
Frontier Communications
FYBR
$9.33B
| $4.6M | 0.05% |
+246,821
| New | +$4.6M |
|